Matches in SemOpenAlex for { <https://semopenalex.org/work/W4200112311> ?p ?o ?g. }
Showing items 1 to 87 of
87
with 100 items per page.
- W4200112311 endingPage "192" @default.
- W4200112311 startingPage "186" @default.
- W4200112311 abstract "We aimed to evaluate the safety and efficacy of periurethral hypertonic saline (10% NaCl) injection in the treatment of stress urinary incontinence (SUI) and stress-predominant mixed urinary incontinence (S-MUI) in women.This was a prospective study conducted between January 2014 and April 2018 with 64 women (44 SUI and 21 S-MUI). Patients with SUI and S-MUI were evaluated using the Urinary Distress Inventory 6. Quality of life was evaluated with the Incontinence Quality of Life Scale and lower urinary tract symptoms of the women were evaluated with the International Consultation on Incontinence Questionnaire Female Lower Urinary Tract Symptoms Modules. Incontinence status and treatment success were assessed via the Stamey incontinence grade and pad test.The subjective success rate was 58.5%, and the objective success rate was 81.5%. The rate of reinjection was 21.5%, and the mean duration of reinjection was 8.92 months (3-19 months). Minor adverse effects were observed in 30.4% of the 79 injections. International Consultation on Incontinence Questionnaire Female Lower Urinary Tract Symptoms Modules and Incontinence Quality of Life Scale scores improved remarkably starting from the first month. Urinary Distress Inventory 6 scores in the S-MUI group also improved.The results indicate that hypertonic saline injection is an effective and safe method in the treatment of SUI and S-MUI. Since hypertonic saline is a much cheaper and more accessible substance compared to bulking agents, it seems to be a viable alternative for urinary incontinence treatment in women." @default.
- W4200112311 created "2021-12-31" @default.
- W4200112311 creator A5048448710 @default.
- W4200112311 creator A5073120418 @default.
- W4200112311 creator A5087568030 @default.
- W4200112311 date "2021-12-12" @default.
- W4200112311 modified "2023-09-23" @default.
- W4200112311 title "The new therapeutic option for female stress and stress‐predominant mixed urinary incontinence: Periurethral hypertonic saline (10%) injection" @default.
- W4200112311 cites W1447307234 @default.
- W4200112311 cites W1939499126 @default.
- W4200112311 cites W1985327186 @default.
- W4200112311 cites W2023672118 @default.
- W4200112311 cites W2049449239 @default.
- W4200112311 cites W2059630268 @default.
- W4200112311 cites W2070178484 @default.
- W4200112311 cites W2096785636 @default.
- W4200112311 cites W2111884951 @default.
- W4200112311 cites W2141538242 @default.
- W4200112311 cites W2542247197 @default.
- W4200112311 cites W2917360021 @default.
- W4200112311 cites W2996434192 @default.
- W4200112311 cites W2997064689 @default.
- W4200112311 cites W3001029683 @default.
- W4200112311 cites W3003023465 @default.
- W4200112311 cites W3024050249 @default.
- W4200112311 cites W4235127055 @default.
- W4200112311 cites W4243924488 @default.
- W4200112311 cites W4253168713 @default.
- W4200112311 doi "https://doi.org/10.1111/luts.12422" @default.
- W4200112311 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34898031" @default.
- W4200112311 hasPublicationYear "2021" @default.
- W4200112311 type Work @default.
- W4200112311 citedByCount "1" @default.
- W4200112311 countsByYear W42001123112022 @default.
- W4200112311 crossrefType "journal-article" @default.
- W4200112311 hasAuthorship W4200112311A5048448710 @default.
- W4200112311 hasAuthorship W4200112311A5073120418 @default.
- W4200112311 hasAuthorship W4200112311A5087568030 @default.
- W4200112311 hasConcept C126322002 @default.
- W4200112311 hasConcept C126894567 @default.
- W4200112311 hasConcept C139265228 @default.
- W4200112311 hasConcept C159110408 @default.
- W4200112311 hasConcept C197934379 @default.
- W4200112311 hasConcept C2777397205 @default.
- W4200112311 hasConcept C2778531004 @default.
- W4200112311 hasConcept C2779523193 @default.
- W4200112311 hasConcept C2779951463 @default.
- W4200112311 hasConcept C29456083 @default.
- W4200112311 hasConcept C3017567848 @default.
- W4200112311 hasConcept C70410870 @default.
- W4200112311 hasConcept C71924100 @default.
- W4200112311 hasConcept C77411442 @default.
- W4200112311 hasConceptScore W4200112311C126322002 @default.
- W4200112311 hasConceptScore W4200112311C126894567 @default.
- W4200112311 hasConceptScore W4200112311C139265228 @default.
- W4200112311 hasConceptScore W4200112311C159110408 @default.
- W4200112311 hasConceptScore W4200112311C197934379 @default.
- W4200112311 hasConceptScore W4200112311C2777397205 @default.
- W4200112311 hasConceptScore W4200112311C2778531004 @default.
- W4200112311 hasConceptScore W4200112311C2779523193 @default.
- W4200112311 hasConceptScore W4200112311C2779951463 @default.
- W4200112311 hasConceptScore W4200112311C29456083 @default.
- W4200112311 hasConceptScore W4200112311C3017567848 @default.
- W4200112311 hasConceptScore W4200112311C70410870 @default.
- W4200112311 hasConceptScore W4200112311C71924100 @default.
- W4200112311 hasConceptScore W4200112311C77411442 @default.
- W4200112311 hasIssue "3" @default.
- W4200112311 hasLocation W42001123111 @default.
- W4200112311 hasLocation W42001123112 @default.
- W4200112311 hasOpenAccess W4200112311 @default.
- W4200112311 hasPrimaryLocation W42001123111 @default.
- W4200112311 hasRelatedWork W1227345485 @default.
- W4200112311 hasRelatedWork W1531368073 @default.
- W4200112311 hasRelatedWork W1992117870 @default.
- W4200112311 hasRelatedWork W2023676690 @default.
- W4200112311 hasRelatedWork W2024064554 @default.
- W4200112311 hasRelatedWork W2095371716 @default.
- W4200112311 hasRelatedWork W2403232061 @default.
- W4200112311 hasRelatedWork W2546203040 @default.
- W4200112311 hasRelatedWork W3157230460 @default.
- W4200112311 hasRelatedWork W431174236 @default.
- W4200112311 hasVolume "14" @default.
- W4200112311 isParatext "false" @default.
- W4200112311 isRetracted "false" @default.
- W4200112311 workType "article" @default.